Provision of antiviral medication for influenza-like illness through NHS community pharmacy providers

The NHS Surrey Heartlands Integrated Care Board is overseeing a public procurement process for the provision of antiviral medication for influenza-like illnesses through NHS community pharmacy providers in Surrey Heartlands. Classified under CPV code 85149000, and falling within the pharmacy services category, this service aims to promptly treat and manage influenza-like illnesses by reducing complications and spread. Initially set for an award period from 1st April 2024 to 31st March 2026, the contract duration has been amended to run from 1st November 2025 to 31st October 2027, with an approximate lifetime value of £2,000.

The procurement process is currently in the award stage, and the contract is set to benefit local community pharmacies, leveraging direct award procedure C under the Health Care Services Provider Selection Regime Regulations 2023, without prior publication of competition. This contract presents significant growth opportunities for community pharmacies that can deliver antiviral medications efficiently within the region. Pharmacies, such as large chains like Boots Pharmacy, which demonstrated high expertise and prior high-standard service delivery, are well-suited to this opportunity.

The service allows pharmacies to integrate as crucial components of the primary care system, supporting wider community health objectives. The contract also implies potential for increased operational scope during peak flu seasons, offering a valuable revenue stream and enhancing service capacity. Businesses with strong collaboration networks within healthcare settings and those committed to reducing health inequalities would find significant advantage in competing for this contract.